UK Nurse’s Death Linked to Newly Approved Weight-Loss Drug Mounjaro, Sparking Safety Concerns
North Lanarkshire, Scotland — The recent death of a 58-year-old nurse has raised concerns about the safety of a newly approved weight-loss drug in the UK. Susan McGowan, who had served as a nurse at University Hospital Monklands in Airdrie for over three decades, passed away from complications including multiple organ failure and septic shock following her use of tirzepatide, sold under the brand name Mounjaro. McGowan’s death certificate attributes her demise in part to …